IPA Endorses ImmuDyne Line of Immune Support Supplements

MT. KISCO, N.Y., March 26, 2015 (GLOBE NEWSWIRE) — Today, ImmuDyne (immd) announced that the Independent Pharmacy Alliance will endorse ImmuDyne’s full line of Immune Support Products. IPA President John Giampolo stated, “I have been using INR Wellness for more than 10 years and my enhanced immune system has protected me beyond all my expectations. You may recall that about 10 years ago, IPA launched a complex vitamin program to complement your patients’ particular disease states. During the educational process to over 600 IPA members provided by many PhD nutritional experts, I discovered ImmuDyne and how its preventative impact affected me. I can highly recommend this product for all members, their families and their patients. Because of my experience, IPA has contracted with ImmuDyne at very special and affordable pricing. Your patients will surely appreciate your care when their resistance to seasonal illness improves.”

ImmuDyne President and CEO Mark McLaughlin commented, “We appreciate the endorsement from IPA. We can do a lot of good for the 3000 independent pharmacies served by IPA, in the New York, New Jersey markets.” Todd Goldman, ImmuDyne’s Sr. Vice President, added, “ImmuDyne is prepared to do whatever is necessary to be a solid partner for IPA and the independent pharmacies. There is no doubt we will bring in additional sales professionals, as needed, to best serve this opportunity, as well as others we are developing.”

Mr. Goldman went on to add, “Millions of American suffer from a suppressed immune system. Immune responses are many times depressed by various external influences including emotional stress, physical stressors such as inadequate sleep or athletic overtraining, environmental and occupational chemical exposure, UV and other types of radiation, common viral or bacterial infections, certain drug therapies, blood transfusions and operations. The human immune system is highly complex and important to our well-being. A strong and balanced immune system is required for health maintenance. Studies show by using ImmuDyne’s beta glucan, it is possible to help restore an immune system imbalance or weakness.”

For more information about ImmuDyne’s full line of products call Todd Goldman at 813-444-1014 or go to www.immudyne.com

About ImmuDyne

ImmuDyne manufactures and sells proprietary, clinically researched, doctor-recommended, yeast beta-1,3/1,6glucan immune support supplements and topical skin care products. ImmuDyne has a portfolio of unique proprietary and patent-protected products with applications in the wellness, skin care, anti-aging, fitness, and health markets. ImmuDyne has offices located in Mt. Kisco, NY, and Florence, KY. PURACERE, iNR Start, iNR Strength, iNR Wellness, and iNR Wellness MD are trademarks of ImmuDyne, Inc. ImmuDyne shares trade under the ticker symbol IMMD and the Company can be found on the web at www.immudyne.com

About Independent Pharmacy Alliance

Independent Pharmacy Alliance, est. 1988, is a trade group and retail pharmacy buying cooperative representing over 3,000 independent pharmacies in New Jersey, New York, Connecticut and Pennsylvania. IPA represents its members for the purpose of combined purchasing to lower a pharmacy’s “cost of goods and services” as well as to provide them with comprehensive legislative advocacy, third party resolution support and free continuing education. If you would like more information concerning IPA, please call Kathy Fuller, Director of Operations, at 800-575-2667 or info@ipagroup.org. http://www.ipagroup.org

Cautionary language regarding Forward-Looking Statements Safe Harbor Act Disclaimer: Forward-looking statements in this release are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Certain statements in this press release may contain words such as “anticipates,” “believes,” “could,” “estimates,” “expects,” “intends,” “may,” “projects,” “plans,” “targets” and other similar language and are considered forward-looking statements. These statements are based on management’s current expectations, estimates, and forecasts. These forward-looking statements are subject to important assumptions, risks and uncertainties, which are difficult to predict and therefore the actual results may be materially different from those discussed.

Source Article from http://finance.yahoo.com/news/ipa-endorses-immudyne-line-immune-164800878.html

This entry was posted in News & Info. Bookmark the permalink. Follow any comments here with the RSS feed for this post. Post a comment or leave a trackback: Trackback URL.

Post a Comment

Your email is never published nor shared. Required fields are marked *

*
*